Press release
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2020
- Third Quarter includes Delivery of Approximately 134,000 Courses of TPOXX® to U.S. Government – - In October, the Public Health Agency of Canada Announced
About this update from Siga Technologies Inc.
[{"type":"text","content":"- Third Quarter includes Delivery of Approximately 134,000 Courses of TPOXX® to U.S. Government –\n - In October, the Public Health Agency of Canada Announced its Intent to Purchase up to 33,300 Courses of Oral TPOXX® – - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today reported financial results for the three and nine months ended September 30, 2020. “SIGA’s third quarter was highlighted by the delivery of approximately 134,000 courses of oral TPOXX® to the strategic national stockpile (SNS),” said Phil Gomez, CEO of SIGA. “With deliveries made in the second quarter, SIGA has delivered approximately 251,000 courses of oral TPOXX® to the SNS over the last two quarters, generating revenue from these deliveries of approximately $78 million. This activity in the U.S. is being complemented by a growing international business, with the most recent activity being the announcement by the Public Health Agency of Canada of its intent to purchase up to 33,300 courses of oral TPOXX® over a five-year time period.” Summary Financial Results ($ in millions, except per share amounts) Three Months Ended September 30, 2020 in comparison to Three Months Ended September 30, 2019 Three Months Ended September 30, 2020 Three Months Ended September 30, 2019Total Revenues Operating Income (1) Income (Loss) before Income Taxes (1) Net Income (Loss) Diluted Income (Loss) per Share$44.3 $32.9 $31.6 $24.2 $0.31 $8.1 $0.7 ($1.6) ($1.2) ($0.03) Nine Months Ended September 30, 2020 in comparison to Nine Months Ended September 30, 2019 Nine Months Ended September 30, 2020 Nine Months Ended September 30, 2019Total Revenues Operating Income (1) Income (Loss) before Income Taxes (1) Net Income (Loss) Diluted Income (Loss) per Share$87.2 $57.7 $47.3 $36.2 $0.45 $22.5 $1.1 ($3.7) ($2.7) ($0.09) (1) Operating Income excludes, and Income (Loss) before Income Taxes includes, costs in connection with the retirement of the Company’s term loan, interest expense, interest income and adjustments to the fair value of the Company’s outstanding warrant. Both line items exclude the impact of income taxes. Recent Key Activities: In the third quarter of 2020, the Company delivered approximately 134...